Start here
The short version: Syringe services programs are one of the most rigorously studied HIV-prevention interventions in public health. The CDC says explicitly that SSPs do not increase drug use, do not increase crime, and substantially reduce HIV and hepatitis C transmission — while dramatically increasing entry into treatment for people who want it.1 They also distribute naloxone, do wound care, test for HIV and hepatitis C, and refer to PrEP, ART, buprenorphine, and methadone.
CDC’s technical package summarizes studies in which regular SSP users were more likely to enter substance-use treatment than people who had never used an SSP. These findings support offering treatment and other care through syringe programs; they do not guarantee the same outcome for every participant.2
You do not need to be sober, in treatment, or ready to quit to use an SSP. That is the point. This page is written for you if you inject, know someone who does, or want to volunteer or donate to a local SSP.
What syringe services programs actually do
- Sterile syringes. Needs-based distribution is recommended by CDC to support a new sterile syringe for every injection. Some jurisdictions, including Florida, require one-for-one exchange; local rules can limit supply.[10]
- Safe disposal. Sharps containers, drop boxes, and pickup so used needles do not end up in public spaces.
- Naloxone. Many programs provide it free with overdose-response training. It reverses opioid overdose; call 911 and follow the product instructions, including repeat doses when needed.
- HIV and hepatitis C screening. May be available on site or by referral. Ask about privacy and result timing; reactive screening tests need confirmatory follow-up.
- Wound care. Abscesses, cellulitis, endocarditis prevention. Some SSPs have nurses on-site.
- Fentanyl test strips. Some programs provide them with instructions. A negative result does not establish that a drug is safe or rule out fentanyl; strips do not measure dose or detect every dangerous substance.[12]
- PrEP referral. HIV-negative people who inject can access PrEP. Many SSPs have direct links to PrEP providers.
- Treatment linkage. When you are ready, SSPs connect to methadone, buprenorphine, naltrexone, and HIV/HCV care. See substance use & HIV.
- Referrals to housing, food, and legal services. Most SSPs are hubs, not single-service.
- Low-barrier access. Many SSPs do not require insurance or government-issued ID. Ask your local program about registration, age limits, privacy, and available services; requirements vary.
The evidence — three decades of research
SSPs are "safe, effective, and cost-saving"
CDC’s 2024 summary states that SSPs prevent HIV and hepatitis C transmission, do not increase illegal drug use, do not increase crime, and can be cost-saving.1
Federal overview of program benefits
HIV.gov summarizes evidence that comprehensive SSPs reduce HIV and hepatitis C transmission and can connect people to medical care and substance-use treatment, without increasing illegal drug use or crime.3
The 2015 Scott County, Indiana outbreak
The 2014–2015 Scott County, Indiana, HIV outbreak was linked primarily to injection of extended-release oxymorphone, not fentanyl. Indiana authorized an emergency syringe exchange as part of a response that also included testing, HIV treatment, and substance-use services. The outbreak illustrates the importance of access to sterile equipment and care before transmission accelerates.4
How to find an SSP near you
- North American Syringe Exchange Network (NASEN) maintains the largest U.S. locator: nasen.org/directory.6
- SAMHSA treatment locator for substance-use treatment: findtreatment.gov.8
- Your state health department HIV/hepatitis C division typically maintains a list of authorized SSPs in-state.
- Mobile SSPs and street-outreach teams are available in some areas. Ask a local harm-reduction organization about current locations and hours.
- Direct mail supplies. Some organizations (e.g., NEXT Distro) mail sterile supplies and naloxone directly. nextdistro.org.7
Florida In Focus — the local picture
Florida’s 2019 Infectious Disease Elimination Act allowed counties to authorize syringe exchange programs, building on Miami-Dade’s earlier pilot. State law requires one-for-one exchange and provides specified protections for possession of needles and syringes as part of an authorized program; it is not blanket immunity for all drug-related activity.[11]95
- IDEA Exchange (Miami-Dade) — the state's flagship. Multiple sites, mobile outreach, U of Miami-affiliated.
- For other counties, check the Florida DOH program information and confirm the current site, hours, and services before traveling.
- Some rural Florida counties still lack access. Advocacy through Florida-based public-health organizations is ongoing.
Your first visit — what to expect
Many SSPs provide supplies without insurance or government-issued ID and without requiring abstinence. Registration and age rules vary. Call or check the program website before visiting if identification or privacy is a concern.
- Walk in or find the mobile unit. Hours vary; check the locator or call ahead.
- Get sterile supplies. Syringes, cookers, cotton, sterile water, alcohol pads, tourniquets, and safe-disposal container. Some programs also do 1:1 exchange; some don't require exchange at all.
- Get naloxone. Ask for naloxone and training in recognizing and responding to an opioid overdose. Supply and training formats vary; ask how to obtain additional doses.
- Ask about testing. HIV and hepatitis C screening may be offered on site or by referral. Ask about cost, consent, confidentiality, and result reporting; a reactive rapid result requires appropriate follow-up testing.
- Ask about anything. Wound care. Bad batches in the local supply. PrEP. MOUD (medication for opioid use disorder). Housing. Legal help. SSP staff know their local resource landscape.
- Come back. The relationship is the point. Returning can help you stay connected to supplies, trusted staff, and treatment or other services when you want them.
You deserve safety and care whether or not you want to stop using drugs. Syringe services can be a starting point for support on your terms.
Overdose-prevention phone support and psychedelic peer support: know the difference.
Questions people ask
Isn't giving out syringes just enabling drug use?
Decades of research and every major public-health body say no. SSPs do not increase drug use. They do reduce HIV and hepatitis C transmission, reduce overdose deaths through naloxone distribution, and connect people to treatment. The evidence is exceptionally consistent across countries.
Is it legal to carry syringes if I got them from an SSP?
In most U.S. states now, yes — but paraphernalia laws vary. Ask your local SSP; they know the specific answer for your county. Some SSPs provide ID cards documenting participation.
Will the SSP report me to the police?
SSPs aim to protect participant privacy, but confidentiality rules and legal exceptions vary. Ask what information is collected and when it may be disclosed. Florida’s authorized programs may not collect personal identifying information under state law; this does not guarantee protection from every law-enforcement interaction.[11]
Can I go to an SSP even if I use snorting or smoking rather than injecting?
You can ask an SSP about services even if you do not inject. Many offer naloxone and referrals regardless of route of use; safer smoking or snorting supplies and test strips depend on local law and program resources.
What if I'm HIV-positive already and use drugs?
SSPs are a strong partner for you. ART adherence, viral suppression, opioid-use-disorder treatment, and mental-health care can all be coordinated through a good SSP or its referral network. See substance use & HIV.
References & Sources
CDC, NIH/NIDA, NASEN, Florida Department of Health, peer-reviewed research on SSPs.
- CDC — Strengthening Syringe Services Programs (2024). Evidence summary: associated with lower HIV/HCV incidence; comprehensive programs are safe, effective and cost-saving and do not increase illegal drug use or crime. ↵ ↵
- CDC/NASTAD — Syringe Services Programs: A Technical Package (2020). See “Access to care” (printed page 16) for treatment-entry and injection-behavior findings. ↵
- HIV.gov. Syringe Services Programs. Federal overview. hiv.gov — federal overview of SSPs ↵
- CDC MMWR. Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone — Indiana, 2015. cdc.gov — Scott County outbreak MMWR ↵
- Florida Department of Health. Infectious Disease Elimination Act. floridahealth.gov ↵
- North American Syringe Exchange Network (NASEN). SSP directory and resources. nasen.org — national directory ↩
- NEXT Distro. Mail-based harm reduction supplies and naloxone. nextdistro.org — mail-order supplies ↩
- SAMHSA. Find substance-use treatment. findtreatment.gov — national locator ↩
- IDEA Exchange, University of Miami. Florida's first legal SSP. ideaexchangeflorida.org — Miami-Dade SSP ↩
- CDC — Syringe Services Programs: A Technical Package of Effective Strategies and Approaches (2020). Source. Checked September 20, 2026. ↩
- Florida Statutes §381.0038 — County authorization, exchange requirements, confidentiality, and limited possession protections. Source. Checked September 20, 2026. ↩
- CDC — Fentanyl and limitations of test strips. Source. Checked September 20, 2026. ↩